Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop

被引：16
作者：
Adrichem, Max E. [1 ]
Eftimov, Filip [1 ]
van Schaik, Ivo N. [1 ]
机构：
[1] Acad Med Ctr Amsterdam, Dept Neurol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2016年 / 21卷 / 03期
关键词：
CIDP; IVIg; long-term treatment; RANDOMIZED CONTROLLED TRIAL; NEONATAL FC-RECEPTOR; IMMUNE GLOBULIN; IVIG RESPONSIVENESS; POLYNEUROPATHY; INFUSION; THERAPY; CIDP; IGG; METHYLPREDNISOLONE;
D O I：
10.1111/jns.12176
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Intravenous immunoglobulin (IVIg) is often used as preferred treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Several studies highlighted the short-term efficacy of IVIg for CIDP yet many patients need maintenance therapy. Notwithstanding the fact IVIg has been used for over 30 years in CIDP, there is only limited evidence to guide dosage and interval during maintenance treatment. The variation in disease course, lack of biomarkers, and fear of deterioration after stopping IVIg makes long-term treatment challenging. Recent studies suggest a proportion of patients receive unnecessary IVIg maintenance treatment. This review provides an overview of the use of IVIg for CIDP treatment, focusing on evidence for long-term IVIg use.
引用
收藏
页码：121 / 127
页数：7
相关论文
共 50 条
[31]   Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand [J].
Bamrungsawad, Naruemon ;
Upakdee, Nilawan ;
Pratoomsoot, Chayanin ;
Sruamsiri, Rosarin ;
Dilokthornsakul, Piyameth ;
Dechanont, Supinya ;
Wu, David Bin-Chia ;
Dejthevaporn, Charungthai ;
Chaiyakunapruk, Nathorn .
CLINICAL DRUG INVESTIGATION, 2016, 36 (07) :557-566
[32]   Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy [J].
Hughes, Richard A. C. ;
Mehndiratta, Man Mohan ;
Rajabally, Yusuf A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11)
[33]   CLINICAL RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN IN ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY [J].
Buraga, Ioan ;
Martin, Roxana-Elena ;
Dobrescu, Adrian ;
Buraga, Ioana .
FARMACIA, 2013, 61 (05) :957-965
[34]   Investigated and emerging treatments for chronic inflammatory demyelinating polyradiculoneuropathy [J].
Leger, Jean-Marc ;
Ashtiani, Bahram Haghi ;
Guimaraes-Costa, Raquel .
EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (03) :261-268
[35]   Chronic Inflammatory Demyelinating Polyradiculoneuropathy [J].
Shije, Jeffrey ;
Brannagan, Thomas H., III .
SEMINARS IN NEUROLOGY, 2019, 39 (05) :596-607
[36]   Chronic Inflammatory Demyelinating Polyradiculoneuropathy [J].
Richard Hughes .
Journal of Clinical Immunology, 2010, 30 :70-73
[37]   Time for a standardized diagnostic response test in patients with chronic inflammatory demyelinating polyradiculoneuropathy? [J].
Szepanowski, Fabian ;
Schoser, Benedikt ;
Mausberg, Anne K. ;
Kleinschnitz, Christoph ;
Hartung, Hans-Peter ;
Stettner, Mark .
BRAIN AND BEHAVIOR, 2023, 13 (11)
[38]   Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). [J].
Kuntzer, T .
REVUE NEUROLOGIQUE, 2006, 162 (04) :539-543
[39]   Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations [J].
Dalakas, Marinos C. C. ;
Latov, Norman ;
Kuitwaard, Krista .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, :953-962
[40]   Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC) [J].
Bus, S. R. M. ;
Zambreanu, L. ;
Abbas, A. ;
Rajabally, Y. A. ;
Hadden, R. D. M. ;
de Haan, R. J. ;
de Borgie, C. A. J. M. ;
Lunn, M. P. ;
van Schaik, I. N. ;
Eftimov, F. .
TRIALS, 2021, 22 (01)
12345